相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study
Kin-Long Chow et al.
HISTOPATHOLOGY (2017)
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma
Oliver Zivanovic et al.
CANCER (2012)
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis
Emanuela D'Angelo et al.
GYNECOLOGIC ONCOLOGY (2011)
Mitosis-specific Marker Phospho-histone H3 in the Assessment of Mitotic Index in Uterine Smooth Muscle Tumors: A Pilot Study
Emanuela Veras et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2009)
Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas - Emphasis on impact of lymphadenectomy and oophorectomy
Daniel S. Kapp et al.
CANCER (2008)
Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors
Longwen Chen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential
C. J. O'Neill et al.
HISTOPATHOLOGY (2007)
Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma
AL Leiser et al.
GYNECOLOGIC ONCOLOGY (2006)
Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity
C Tapia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)
K Mayerhofer et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2004)
分享论文
